Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Low-Cost, Easy to Use COVID-19 Saliva Test Provides Accurate Results within 30 Minutes

By LabMedica International staff writers
Posted on 08 Dec 2020
An at-home, COVID-19 saliva test that is designed to cost USD 5 or less uses no electricity and provides accurate results within 30 minutes.

The low-cost, fast saliva test for COVID-19 that will be the focus of a study at Stanford University School of Medicine (Stanford, CA, USA) involves little more than boiling some water, reading some instructions and spitting into a funnel. More...
The test takes no more than 10 minutes to self-administer and is designed to detect the presence or absence of SARS-CoV-2 in saliva within 30 minutes, with an accuracy rate similar to that of the clinical tests performed in hospitals. A color display will appear yellow if there is a coronavirus infection or pink if there is no infection. The researchers estimate the kit’s retail cost, if the test is approved, to be as low as USD 5 and perhaps closer to USD 1. The test is also designed for easy, large-scale manufacture, which is crucial in the current pandemic.

“The world needs rapid-screening kits now, and at a very large scale,” said Manu Prakash, PhD, associate professor of bioengineering and the inventor of the test. “If the study is successful, our goal will be to manufacture tens of millions of them per day. We’re already building industrial partnerships to generate that capacity.”

“Our hope is to prove this works in the real world and then scale to hundreds of millions of tests to help open schools, universities and businesses as we wait for the vaccines now in development to come online,” said Euan Ashley, MB ChB, DPhil, associate dean in the School of Medicine and professor of cardiovascular medicine, of genetics and of biomedical data science.

Related Links:
Stanford Medicine


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Online QC Software
Acusera 24•7
Pipette Calibration System
Artel PCS®
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.